跳转至内容
Merck
CN

O-002

羟考酮标准液 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

登录 查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C18H21NO4
化学文摘社编号:
76-42-6
分子量:
315.36
EC 号:
200-659-6
MDL编号:
MFCD00190613
UNSPSC代码:
41116107
PubChem化学物质编号:
329818811
NACRES:
NA.24

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

等级

certified reference material

质量水平

300

表单

liquid

特点

Snap-N-Spike®/Snap-N-Shoot®

包装

ampule of 1 mL

制造商/商品名称

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
kontrollierte Droge in Deutschland

浓度

1.0 mg/mL in methanol

技术

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

应用

forensics and toxicology

包装形式

single component solution

储存温度

2-8°C

SMILES字符串

COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O

InChI

1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1

InChI key

BRUQQQPBMZOVGD-XFKAJCMBSA-N

基因信息

human ... OPRM1(4988)

正在寻找类似产品? 访问 产品对比指南

相关类别

一般描述

该认证的加标溶液®适用于从临床毒理学和尿液药物测试到法医分析的羟考酮GC/MS或LC/MS测试的许多应用。羟考酮是一种半合成阿片类镇痛药，以许多商品名出售，包括OxyContin®和Percocet®，用于治疗中度至重度疼痛。羟考酮还以“Roxies”，“Blues”和“Perks”等街头名称非法出售。

其他说明

在我们的NMR在线平台ChemisTwin®上可以找到本品对应的数字化标准物质。您可使用ChemisTwin®上的数字等效品鉴定您的样品并进行定量分析（使用数字化外标）。可查看该物质的NMR谱图，只需点击几次鼠标，就能进行在线样品比对。欢迎点击了解更多，开启免费试用之旅。

法律信息

German
Dieses Produkt fällt unter das Betäubungsmittelgesetz (BtMG). Für eine Bestellung dieses Produktes ist eine Erlaubnis nach § 3 BtMG zwingend erforderlich, es sei denn, es greift eine Ausnahme von der Erlaubnispflicht nach § 4 oder § 26 BtMG.

English
This product is subject to the German Narcotics Act. A permit under Section 3 of the German Narcotics Act is mandatory for ordering this product unless an exemption from the permit requirement under Section 4 or Section 26 of the German Narcotics Act applies.
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
OxyContin is a registered trademark of Purdue Pharma L.P.
Percocet is a registered trademark of Endo Pharmaceuticals Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

警示用语：

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

靶器官

Eyes,Central nervous system

储存分类代码

3 - Flammable liquids

WGK

WGK 2

闪点(°F)

49.5 °F - closed cup

闪点(°C)

9.7 °C - closed cup

法规信息

监管及禁止进口产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Myoung Kim et al.
Journal of opioid management, 9(3), 189-204 (2013-06-19)
This article describes the rationale and design of the Oxycodone Users Registry (OUR) study and lessons learned during study development and data collection. The OUR study used a prospective registry design. Sixty-five academic and private medical practices across the United
Kenneth Kirsh et al.
Journal of pain & palliative care pharmacotherapy, 26(4), 348-361 (2013-05-16)
Prescription opioids are prescribed increasingly for the management of chronic pain, and this has been accompanied by a dramatic rise in opioid-related abuse, addiction, and overdose deaths. Reports of abuse involving nonoral administration (e.g., snorting, injecting) of prescription opioids are
FDA ban of generic oxycodone calls into question Health Canada's approval.
Adam Miller
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 185(9), E381-E382 (2013-05-01)
Sanjay Merchant et al.
Journal of opioid management, 9(1), 51-61 (2013-05-28)
To evaluate a composite measure for chronic pain that balances pain relief with tolerability. Post hoc meta-analysis of three randomized, multicenter, double-blind studies. Subjects with moderate-to-severe chronic osteoarthritis knee pain or low back pain who had been randomized to receive
Jessica L Asay et al.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 31(7), 1007-1012 (2013-03-20)
Gait measures are receiving increased attention in the evaluation of patients with knee osteoarthritis (OA). Yet, there remains a need to assess variability of gait analysis in patients with knee osteoarthritis over time and how pain affects variation in these
查看所有相关文献

商品

Benefits of Ascentis Express Phenyl-Hexyl over Biphenyl for the Separation of Pain Management Opiates

Although both biphenyl and phenyl-hexyl phases can resolve these compounds, the former exhibits excellent peak shape and substantially less silanol-derived ion exchange activity.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持